Novo Nordisk filed a patent infringement lawsuit against Hims & Hers over compounded versions of Wegovy. The legal action follows the telehealth company's announcement of a $49 oral pill, which was withdrawn after FDA warnings.
Australian regulators confirmed counterfeit GLP-1 products contain no active ingredients, while U.S. authorities escalate enforcement against compounded weight-loss drugs as Novo Nordisk sues telehealth company Hims & Hers.
Eli Lilly achieved positive outcomes for nearly all R&D key events in 2025, with successful phase 3 trials for cancer drug Jaypirca, next-gen obesity medicine retatrutide, and oral GLP-1 orforglipron, while Alzheimer's drug Kisunla showed cognitive decline benefits.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07765394 |
A Clinical Trial to Evaluate the Effects of A Supplement on Supporting Signs of Metabolic Health |
COMPLETED | NA |
| NCT07717658 |
Family-Based Weight Wellness Treatment Through Food is Medicine and Group Medical Visits in Pediatric and Adult Primary Care |
RECRUITING | NA |
| NCT07667803 |
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM |
RECRUITING | PHASE3 |
| NCT07604649 |
TTM-Based Intervention for Weight Management Among High School Female Students |
NOT_YET_RECRUITING | NA |
| NCT07559409 |
CORE Study - Research Into Weight Management Services in the UK |
ENROLLING_BY_INVITATION | |
| NCT07505303 |
MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial |
ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT07451639 |
White Mulberry Leaf Extract for Metabolic Health in Overweight Adults Taking Metformin |
COMPLETED | NA |
| NCT07426952 |
Weight Management After Cancer for Survivors in Rural Communities |
RECRUITING | NA |
| NCT07272824 |
Usability Study of Gestational and Postpartum Weight Management Program |
RECRUITING | |
| NCT07243171 |
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity |
RECRUITING | PHASE1/PHASE2 |
